个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

PCYT1A suppresses proliferation and migration via inhibiting mTORC1 pathway in lung adenocarcinoma

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Jing Yu[a,b] ; Changtao Wu[b,c] ; Qi Wu[b] ; Jiafeng Huang[b] ; Wenjuan Fu[b] ; Xuemei Xie[d] ; Wen Li[f] ; Weizhong Tang[e] ; Chuan Xu[a,f,*1] ; Guoxiang Jin[b] ;
机构： [a]Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China [b]Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), And Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China [c]Department of Colorectal and Anal Surgery, The First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, China [d]Department of Pathology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, 637100, China [e]Department of Gastrointestinal Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, 530021, China [f]Integrative Cancer Center & Cancer Clinical Research Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine University of Electronic Science and Technology of China, Chengdu, 610047, China
出处：
DOI： 10.1016/j.bbrc.2020.05.164
ISSN：

关键词： Lung adenocarcinoma Migration mTORC1 signaling PCYT1A Proliferation

摘要：
Lung cancer is one of most common malignant cancer worldwide. It is emerging that PCYT1A, a rate-limiting enzyme required for the biosynthesis of phosphatidylcholine, is associated with cancer progression. However, the biological functions and underlying molecular mechanisms of PCYT1A in lung adenocarcinoma is still unknown. Here we found that PCYT1A suppressed lung adenocarcinoma cancer cell proliferation and migration. Mechanically, PCYT1A served as a novel negative regulator of mTORC1 signaling. PCYT1A knockdown enhanced the malignant proliferation and migration of lung adenocarcinoma cells by activating mTORC1. The promoting effects of PCYT1A silencing on cell proliferation and migration could be abolished when mTORC1 signaling was inhibited by rapamycin or RAPTOR depletion. Importantly, PCYT1A high expression predicted longer survival of lung cancer patients. The expression of PCYT1A was also negatively correlated with mTORC1 activation in the clinical lung cancer samples. We therefore reveal that PCYT1A suppresses proliferation and migration by inhibiting the mTORC1 signaling pathway in lung adenocarcinoma. PCYT1A shows as a potential promising biomarker in lung adenocarcinoma. © 2020 Elsevier Inc.

基金：
This study was supported by the National Natural Science Foundation of China (81773040 to G.J.); and the Chongqing Science and Technology Commission (cstc2018jcyj-yszxX0011, cstc2018jcyjAX0655 to G.J.)
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2020]版：
大类 | 3 区 生物学
小类 | 3 区 生物物理 4 区 生化与分子生物学
最新[2023]版：
大类 | 3 区 生物学
小类 | 3 区 生物物理 4 区 生化与分子生物学
JCR分区：
出版当年[2020]版：
Q2 BIOPHYSICS Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
最新[2023]版：
Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Q3 BIOPHYSICS

影响因子： 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者：
第一作者机构： [a]Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China [b]Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), And Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China
共同第一作者：
通讯作者：
通讯机构： [a]Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China [f]Integrative Cancer Center & Cancer Clinical Research Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine University of Electronic Science and Technology of China, Chengdu, 610047, China [*1]Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
推荐引用方式(GB/T 7714)：
Jing Yu,Changtao Wu,Qi Wu,et al.PCYT1A suppresses proliferation and migration via inhibiting mTORC1 pathway in lung adenocarcinoma[J].BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS.2020,529(2):353-361.doi:10.1016/j.bbrc.2020.05.164.
APA：
Jing Yu,Changtao Wu,Qi Wu,Jiafeng Huang,Wenjuan Fu...&Guoxiang Jin.(2020).PCYT1A suppresses proliferation and migration via inhibiting mTORC1 pathway in lung adenocarcinoma.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,529,(2)
MLA：
Jing Yu,et al."PCYT1A suppresses proliferation and migration via inhibiting mTORC1 pathway in lung adenocarcinoma".BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 529..2(2020):353-361

相关文献

[1]lncRNA FEZF1-AS1 Is Associated With Prognosis in Lung Adenocarcinoma and Promotes Cell Proliferation, Migration, and Invasion [2]lncRNA FEZF1-AS1 Is Associated With Prognosis in Lung Adenocarcinoma and Promotes Cell Proliferation, Migration, and Invasion [3]STAT1-induced upregulation of LINC00467 promotes the proliferation migration of lung adenocarcinoma cells by epigenetically silencing DKK1 to activate Wnt/beta-catenin signaling pathway [4]MicroRNA-183 promotes migration and invasion of CD133(+)/CD326(+) lung adenocarcinoma initiating cells via PTPN4 inhibition. [5]肺腺癌转移相关转录本1调控喉癌细胞的增殖和侵袭 [6]Spinosad blocks CHRNA5 mediated EGFR signaling pathway activation to inhibit lung adenocarcinoma proliferation [7]Dihydroartemisinin Inhibits mTORC1 Signaling by Activating the AMPK Pathway in Rhabdomyosarcoma Tumor Cells. [8]Deubiquitinating enzyme USP41 promotes lung cancer cell proliferation and migration. [9]槲皮素对人肝癌细胞生长、迁移能力的影响及机制研究 [10]CEP131 indicates poor prognosis and promotes cell proliferation and migration in hepatocellular carcinoma

资源点击量：43377 今日访问量：0 总访问量：3120 更新日期：2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号